The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy
Open accessAbstract
Nuclear factor κ-B (NFκB) is activated in iPSC-cardiac myocytes from patients with arrhythmogenic cardiomyopathy (ACM) under basal conditions, and inhibition of NFκB signaling prevents disease in Dsg2 mut/mut mice, a robust mouse model of ACM. Here, we used genetic approaches and single-cell RNA-Seq to define the contributions of immune signaling in cardiac myocytes and macrophages in the natural progression of ACM using Dsg2 mut/mut mice. We found that NFκB signaling in cardiac myocytes drives myocardial injury, contractile dysfunction, and arrhythmias in Dsg2 mut/mut mice. NFκB signaling in cardiac myocytes mobilizes macrophages expressing C-C motif chemokine receptor-2 (CCR2 + cells) to affected areas within the heart, where they mediate myocardial injury and arrhythmias. Contractile dysfunction in Dsg2 mut/mut mice is caused both by loss of heart muscle and negative inotropic effects of inflammation in viable muscle. Single nucleus RNA-Seq and cellular indexing of transcriptomes and epitomes (CITE-Seq) studies revealed marked proinflammatory changes in gene expression and the cellular landscape in hearts of Dsg2 mut/mut mice involving cardiac myocytes, fibroblasts, and CCR2 + macrophages. Changes in gene expression in cardiac myocytes and fibroblasts in Dsg2 mut/mut mice were dependent on CCR2 + macrophage recruitment to the heart. These results highlight complex mechanisms of immune injury and regulatory crosstalk between cardiac myocytes, inflammatory cells, and fibroblasts in the pathogenesis of ACM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent works have demonstrated CCR2+ macrophages are early and persistent drivers of cardiac inflammation in ACM [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The germline Dsg2mut/mut mouse model developed by Chelko SP and colleagues represents a more genetically relevant system for studying ACM pathogenesis, as the Dsg2 mutation is germline, mirroring the pattern of inheritance observed in patients [12,60].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Direct pharmacologic inhibition of the master regulator of inflammatory signaling, NFκB, via the small molecule Bay 11-7082, normalized myocardial levels of several pro-inflammatory cytokines (e.g., IL-1β, IFN-γ, and IL-12), chemokines (e.g., LIX and CCL2), and fibrokines (e.g., OPN and POSTN) with ameliorated myocardial injury and improvement in cardiac function [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further analyses identified expansion of inflammatory macrophage subsets interacting with activated fibroblast populations, forming inflammatory–fibrotic niches that promote cardiac remodeling [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-omic analyses, including single-nucleus RNA sequencing (snRNAseq) and cellular indexing of transcriptomes and epitopes sequencing (CITE-Seq), demonstrated inflammatory transcriptional reprogramming across cardiomyocytes, fibroblasts, and both myeloid and lymphoid lineage cells, indicating extensive immune–stromal crosstalk during disease progression [12].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,612
Self-citationRight Ventricular Dysplasia: A Report of 24 Adult Cases
Marcus, F. I., Fontaine, G. H., Guiraudon, G., Frank, R., Laurenceau, J. L., Malergue, C., & Grosgogeat, Y. (1982) · Circulation · doi:10.1161/01.cir.65.2.384 · Cited by 1,603
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., & Baeuerle, P. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07287.x · Cited by 1,013
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978
Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., Mohan, J., Ivey, B., Hsiao, H.-M., Weinheimer, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314028 · Cited by 751
Self-citationGarcia-Gras, E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27751 · Cited by 623
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599 · cited 2×
“…of NF κ B in cardiac myocytes and CCR2 + macrophage recruitment in the pathogenesis of ACM, we compared phenotypes of 8-and 16-week-old WT, Dsg2 mut/mut , Dsg2 mut/mut × I κ B αΔ N, and Dsg2 mut/mut crossed with a mouse line with germ-line deletion of Ccr2 (22) (i.e., Dsg2 mut/mut × Ccr2 –/– mice).”
Li, W., Feng, G., Gauthier, J. M., Lokshina, I., Higashikubo, R., Evans, S., Liu, X., Hassan, A., Tanaka, S., Cicka, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126428 · Cited by 492
Self-citationSingle-cell transcriptomics reveals cell-type-specific diversification in human heart failure
Koenig, A. L., Shchukina, I., Amrute, J., Andhey, P. S., Zaitsev, K., Lai, L., Bajpai, G., Bredemeyer, A., Smith, G., Jones, C., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00028-6 · Cited by 482
Self-citationSingle-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Chaffin, M., Papangeli, I., Simonson, B., Akkad, A.-D., Hill, M. C., Arduini, A., Fleming, S. J., Melanson, M., Hayat, S., Kost-Alimova, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04817-8 · Cited by 418
Corrado, D., van Tintelen, P. J., McKenna, W. J., Hauer, R. N. W., Anastastakis, A., Asimaki, A., Basso, C., Bauce, B., Brunckhorst, C., Bucciarelli-Ducci, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz669 · Cited by 366
Self-citationTargeting immune–fibroblast cell communication in heart failure
Amrute, J. M., Luo, X., Penna, V., Yang, S., Yamawaki, T., Hayat, S., Bredemeyer, A., Jung, I.-H., Kadyrov, F. F., Heo, G. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08008-5 · Cited by 339
Self-citationPrimitive Embryonic Macrophages are Required for Coronary Development and Maturation
Leid, J., Carrelha, J., Boukarabila, H., Epelman, S., Jacobsen, S. E. W., & Lavine, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.308270 · Cited by 329
Self-citationAsimaki, A., Kapoor, S., Plovie, E., Karin Arndt, A., Adams, E., Liu, Z., James, C. A., Judge, D. P., Calkins, H., Churko, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008008 · Cited by 274
Self-citationA transcriptional switch governs fibroblast activation in heart disease
Alexanian, M., Przytycki, P. F., Micheletti, R., Padmanabhan, A., Ye, L., Travers, J. G., Gonzalez-Teran, B., Silva, A. C., Duan, Q., Ranade, S. S., et al. (2021) · Nature · doi:10.1038/s41586-021-03674-1 · Cited by 238 · cited 1×
“These data are consistent with a known role of Postn + fibroblasts in fibrosis-associated myocardial infarction and pressure overload (29, 32, 33).”
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Chelko, S. P., Asimaki, A., Lowenthal, J., Bueno-Beti, C., Bedja, D., Scalco, A., Amat-Alarcon, N., Andersen, P., Judge, D. P., Tung, L., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040676 · Cited by 192 · cited 8×
“Levels of proinflammatory cytokines and fibrokines are increased in hearts of 16-week-old Dsg2 mut/mut mice (6).”
InfluentialSelf-citationMonocytes and Macrophages as Cellular Targets in Liver Fibrosis
Heymann, F., Trautwein, C., & Tacke, F. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809789352230 · Cited by 189
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
Chelko, S. P., Asimaki, A., Andersen, P., Bedja, D., Amat-Alarcon, N., DeMazumder, D., Jasti, R., MacRae, C. A., Leber, R., Kleber, A. G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85923 · Cited by 180
Self-citationHeart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling
Li, W., Hsiao, H.-M., Higashikubo, R., Saunders, B. T., Bharat, A., Goldstein, D. R., Krupnick, A. S., Gelman, A. E., Lavine, K. J., & Kreisel, D. (2016) · JCI Insight · doi:10.1172/jci.insight.87315 · Cited by 162
Self-citationPeriostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
Zhao, S., Wu, H., Xia, W., Chen, X., Zhu, S., Zhang, S., Shao, Y., Ma, W., Yang, D., & Zhang, J. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.09.013 · Cited by 159
Misra, A., Haudek, S. B., Knuefermann, P., Vallejo, J. G., Chen, Z. J., Michael, L. H., Sivasubramanian, N., Olson, E. N., Entman, M. L., & Mann, D. L. (2003) · Circulation · doi:10.1161/01.cir.0000108929.93074.0b · Cited by 158
Kwon, H., Choi, G.-E., Ryu, S., Kwon, S. J., Kim, S. C., Booth, C., Nichols, K. E., & Kim, H. S. (2016) · Nature Communications · doi:10.1038/ncomms11686 · Cited by 153
Genetics of Myocarditis in Arrhythmogenic Right Ventricular Dysplasia
Lopez-Ayala, J. M., Pastor-Quirante, F., Gonzalez-Carrillo, J., Lopez-Cuenca, D., Sanchez-Munoz, J. J., Oliva-Sandoval, M. J., & Gimeno, J. R. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.001 · Cited by 140 · cited 2×
“A histological picture reminiscent of acute myocarditis may reflect an active phase of ACM associated with accelerated disease progression (37).”
Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Asatryan, B., Asimaki, A., Landstrom, A. P., Khanji, M. Y., Odening, K. E., Cooper, L. T., Marchlinski, F. E., Gelzer, A. R., Semsarian, C., Reichlin, T., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055890 · Cited by 132
Chelko, S. P., Keceli, G., Carpi, A., Doti, N., Agrimi, J., Asimaki, A., Beti, C. B., Miyamoto, M., Amat-Codina, N., Bedja, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf0891 · Cited by 92
Self-citationPost-translational Modifications of IκBα: The State of the Art
Wang, X., Peng, H., Huang, Y., Kong, W., Cui, Q., Du, J., & Jin, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.574706 · Cited by 88
Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis
Nanri, Y., Nunomura, S., Terasaki, Y., Yoshihara, T., Hirano, Y., Yokosaki, Y., Yamaguchi, Y., Feghali‐Bostwick, C. A., Ajito, K., Murakami, S., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0245oc · Cited by 77
Braga, T. T., Corrêa-Costa, M., Silva, R. C., Cruz, M. C., Hiyane, M. I., Silva, J. S., Perez, K. R., Cuccovia, I. M., & Câmara, N. O. S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0317-4 · Cited by 74
BESSE, S., Nadaud, S., Balse, E., & Pavoine, C. (2022) · Cells · doi:10.3390/cells11071249 · Cited by 74
Park, S., Ranjbarvaziri, S., Zhao, P., & Ardehali, R. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.01.016 · Cited by 66
Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women
Scheel, P. J., Murray, B., Tichnell, C., James, C. A., Tandri, H., Calkins, H., Chelko, S. P., & Gilotra, N. A. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.090 · Cited by 62
Self-citationThe arrhythmogenic right ventricle. Dysplasia versus cardiomyopathy
Fontaine, G., Fontaliran, F., Rosas Andrade, F., Velasquez, E., Tonet, J., Jouven, X., Fujioka, Y., & Frank, R. (1995) · Heart and Vessels · doi:10.1007/bf01744901 · Cited by 55 · cited 4×
“Inflammation has been recognized in ACM for as long as the disease has been known (4, 5).”
InfluentialGil, H., Goldshtein, M., Etzion, S., Elyagon, S., Hadad, U., Etzion, Y., & Cohen, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-26035-y · Cited by 42
Hawthorne, R. N., Blazeski, A., Lowenthal, J., Kannan, S., Teuben, R., DiSilvestre, D., Morrissette-McAlmon, J., Saffitz, J. E., Boheler, K. R., James, C. A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143061 · Cited by 41
Self-citationTargeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac FibrosisPreprint
Lavine, K. J., Amrute, J., Luo, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2402606/v1 · Cited by 30
Self-citationCCR2 Deficiency Impairs Ly6Clo and Ly6Chi Monocyte Responses in Orientia tsutsugamushi Infection
Petermann, M., Orfanos, Z., Sellau, J., Gharaibeh, M. H., Lotter, H., Fleischer, B., & Keller, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670219 · Cited by 24
Bueno‐Betí, C., Tafuni, A., Chelko, S. P., Sheppard, M. N., Field, E., Tollit, J., Heenan, I., Barnes, A., Taylor, M. R. G., Mestroni, L., et al. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.09.006 · Cited by 12
Self-citationCardiac function in muscular dystrophy associates with abdominal muscle pathology
Gardner, B. B., Swaggart, K. A., Kim, G. H., Watson, S., & McNally, E. M. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140062 · Cited by 10
Cited by
Functional diversity of cardiac macrophages in health and disease
Yang, S. H., Penna, V. R., & Lavine, K. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01109-8 · Cited by 72
Self-citationCardiac fibroblasts in myocardial injury and heart failure
Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 47
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies
Bassetto, G., Angriman, F., Gava, C. P. L. D., Paldino, A., Perotto, M., Bordignon, L., Gigli, M., Ferro, M. D., Massa, L., Altinier, A., et al. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02168-6 · Cited by 41
Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy
Penna, V. R., Amrute, J., Engel, M., Shiel, E. A., Farra, W., Cannon, E. N., Leu-Turner, C., Ma, P., Villanueva, A., Shin, H.-W., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101542 · Cited by 15
Self-citationPeretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
Metadata
- Authors
- Chelko, S. P., Penna, V. R., Engel, M., Shiel, E. A., Centner, A. M., Farra, W., Cannon, E. N., Landim-Vieira, M., Schaible, N., Lavine, K., & Saffitz, J. E.
- Affiliations
- Florida State University (US)
- Washington University in St. Louis (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Chelko, Stephen P.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2024-04-02
- Volume
- 134
- Issue
- 10
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11093597
- OpenAlex
- W4393549560
- Cited by
- 32
- References
- 43
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 6
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01-HL148348, P30AR073752, R35 HL161185, 5T32AI007163-44)
- American Heart Association (19CDA34760185)
- Fondation Leducq (#20CVD02)
- Burroughs Wellcome Fund (1014782)
- Children’s Discovery Institute (CH-II-2015-462,CH-II-2017-628)
- St. Louis Children’s Hospital (PM-LI-2019-829)
- Foundation of Barnes-Jewish Hospital (8038-88)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- arrhythmogenic cardiomyopathy, NF-κB signaling, CCR2+ macrophages, myocardial injury, cardiomyocytes, macrophage recruitment, cardiac arrhythmias, contractile dysfunction, cardiac fibroblasts, inflammation, single-cell RNA sequencing, CITE-seq
- MeSH terms
- Animals, Disease Models, Animal, Humans, Macrophages, Myocardium, Signal Transduction, NF-kappa B, Arrhythmogenic Right Ventricular Dysplasia, Myocytes, Cardiac, Desmoglein 2, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.